Home LiteratureArticle Details
PMID: 1326651 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Transient replication of human papillomavirus DNAs.

Journal of virology ·Vol. 66 ·No. 10 ·1992-10-00 ·Pages 5949-58

Del Vecchio AM, Romanczuk H, Howley PM, Baker CC

Abstract

Information on papillomavirus DNA replication has primarily derived from studies with bovine papillomavirus type 1 (BPV-1). Our knowledge of DNA replication of the human papillomaviruses (HPVs) is quite limited, in part because of the lack of a cell culture system capable of supporting the stable replication of HPV DNA. This study demonstrates that the full-length genomic DNAs of HPV types 11 and 18 (HPV-11 and HPV-18), but not HPV-16, are able to replicate transiently after transfection into several different human squamous cell carcinoma cell lines. This system was used to identify the viral cis and trans elements required for DNA replication. The viral origins of replication were localized to a region of the viral long control region. Like BPV-1, E1 and E2 were the only viral factors required in trans for the replication of plasmids containing the origin. Cotransfection of a plasmid expressing the E1 open reading frame (ORF) from HPV-11 with a plasmid that expresses the E2 ORF from HPV-6, HPV-11, HPV-16, or HPV-18 supported the replication of plasmid DNAs containing the origin regions of HPV-11, HPV-16, or HPV-18, indicating that there are functions shared among the corresponding E1 and E2 proteins and origins of these viruses. Although HPV-16 genomic DNA did not replicate by itself under experimental conditions that supported the replication of HPV-11 and HPV-18 genomic DNAs, expression of the HPV-16 early region functions from a strong heterologous promoter supported the replication of a cotransfected plasmid containing the HPV-16 origin of replication. This finding suggests that the inability of the HPV-16 genomic DNA to replicate transiently in the cell lines tested was most likely due to insufficient expression of the viral E1 and/or E2 genes required for DNA replication.

MeSH Terms
Base Sequence Blotting, Southern DNA Replication DNA, Viral/biosynthesis Humans Molecular Sequence Data Open Reading Frames Papillomaviridae/genetics,metabolism Plasmids Promoter Regions, Genetic Transfection Tumor Cells, Cultured
Chemicals
DNA, Viral
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Del Vecchio A M
Laboratory of Tumor Virus Biology, National Cancer Institute, Bethesda, Maryland 20892.
Romanczuk H
Howley P M
Baker C C
References (52)
52 references, click to expand
  1. Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18.
    J Virol. 1988 Mar;62(3):665-72 PMID: 2828662
  2. Proteins encoded by the bovine papillomavirus E1 open reading frame: expression in heterologous systems and in virally transformed cells.
    J Virol. 1990 Dec;64(12):6027-39 PMID: 2173778
  3. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells.
    Nature. 1985 Mar 7-13;314(6006):111-4 PMID: 2983228
  4. Genetic analysis of the 3' early region transformation and replication functions of bovine papillomavirus type 1.
    Virology. 1986 Apr 15;150(1):221-30 PMID: 3006336
  5. Bovine papillomavirus type 1 3' early region transformation and plasmid maintenance functions.
    J Virol. 1986 Nov;60(2):626-34 PMID: 3021996
  6. Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens.
    J Virol. 1987 Jan;61(1):134-42 PMID: 3023691
  7. Selective extraction of polyoma DNA from infected mouse cell cultures.
    J Mol Biol. 1967 Jun 14;26(2):365-9 PMID: 4291934
  8. Molecular cloning of viral DNA from human genital warts.
    J Virol. 1981 Dec;40(3):932-5 PMID: 6275126
  9. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.
    Proc Natl Acad Sci U S A. 1983 Jun;80(12):3812-5 PMID: 6304740
  10. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.
    EMBO J. 1984 May;3(5):1151-7 PMID: 6329740
  11. Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.
    J Virol. 1989 Jul;63(7):2967-76 PMID: 2542607
  12. The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency.
    J Virol. 1992 Apr;66(4):2346-58 PMID: 1312634
  13. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity.
    Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3159-63 PMID: 1313584
  14. Replication of plasmid-derived human papillomavirus type 11 DNA in cultured keratinocytes.
    J Virol. 1992 May;66(5):3220-4 PMID: 1313926
  15. Papillomavirus DNA replication.
    J Virol. 1991 Jul;65(7):3417-20 PMID: 1645776
  16. Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated.
    Nucleic Acids Res. 1991 May 11;19(9):2363-71 PMID: 1645869
  17. Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1.
    Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6363-7 PMID: 1648739
  18. A bovine papillomavirus E1-related protein binds specifically to bovine papillomavirus DNA.
    J Virol. 1991 Oct;65(10):5314-22 PMID: 1654443
  19. Activation of BPV-1 replication in vitro by the transcription factor E2.
    Nature. 1991 Oct 17;353(6345):628-32 PMID: 1656277
  20. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1.
    EMBO J. 1991 Dec;10(13):4321-9 PMID: 1661672
  21. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease.
    Cell. 1991 Jan 25;64(2):365-80 PMID: 1703046
  22. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm.
    J Virol. 1991 Feb;65(2):606-12 PMID: 1846186
  23. The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro.
    J Virol. 1991 Feb;65(2):649-56 PMID: 1846189
  24. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames.
    EMBO J. 1991 Feb;10(2):449-57 PMID: 1846806
  25. Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region.
    Virology. 1991 Mar;181(1):374-7 PMID: 1847260
  26. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation.
    J Virol. 1991 May;65(5):2254-60 PMID: 1850010
  27. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18.
    J Virol. 1991 May;65(5):2739-44 PMID: 1850048
  28. Identification of a 68-kilodalton nuclear ATP-binding phosphoprotein encoded by bovine papillomavirus type 1.
    J Virol. 1990 Oct;64(10):5093-105 PMID: 2168988
  29. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.
    Cancer Res. 1981 May;41(5):1657-63 PMID: 7214336
  30. Production of human papillomavirus type 16 virions in a keratinocyte cell line.
    J Virol. 1990 Dec;64(12):6305-7 PMID: 2173795
  31. Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16.
    J Gen Virol. 1990 Nov;71 ( Pt 11):2699-707 PMID: 2174960
  32. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator.
    Science. 1990 Dec 21;250(4988):1694-9 PMID: 2176744
  33. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.
    EMBO J. 1987 Dec 1;6(12):3745-53 PMID: 2448139
  34. Properties of a non-tumorigenic human cervical keratinocyte cell line.
    Int J Cancer. 1989 Apr 15;43(4):672-6 PMID: 2467886
  35. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
    J Virol. 1989 Oct;63(10):4317-24 PMID: 2476572
  36. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia.
    J Virol. 1989 Aug;63(8):3261-9 PMID: 2545902
  37. Heterogeneity of the human papillomavirus group.
    J Virol. 1989 Nov;63(11):4898-903 PMID: 2552162
  38. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region.
    EMBO J. 1987 Nov;6(11):3391-7 PMID: 2828029
  39. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
    New Biol. 1990 May;2(5):450-63 PMID: 1963084
  40. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA.
    Lancet. 1990 May 19;335(8699):1171-4 PMID: 1971033
  41. The ethical thinking of animal researchers: problems and prospects.
    New Biol. 1991 Jan;3(1):1-2 PMID: 2039765
  42. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.
    J Virol. 1990 Jun;64(6):2849-59 PMID: 2159546
  43. A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter.
    J Virol. 1990 Oct;64(10):4792-8 PMID: 2168967
  44. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization.
    Med Microbiol Immunol. 1987;176(5):245-56 PMID: 2821369
  45. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.
    EMBO J. 1987 Dec 1;6(12):3735-43 PMID: 2828035
  46. Bovine papillomavirus mutant temperature sensitive for transformation, replication and transactivation.
    EMBO J. 1988 Apr;7(4):1197-204 PMID: 2841117
  47. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours.
    J Gen Virol. 1985 Jul;66 ( Pt 7):1515-22 PMID: 2991428
  48. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein.
    Proc Natl Acad Sci U S A. 1986 Jul;83(13):4680-4 PMID: 3014503
  49. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines.
    J Virol. 1987 Apr;61(4):962-71 PMID: 3029430
  50. Localization and analysis of bovine papillomavirus type 1 transforming functions.
    J Virol. 1984 Nov;52(2):377-88 PMID: 6092667
  51. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma.
    J Virol. 1982 Oct;44(1):393-400 PMID: 6292500
  52. Interplay of viral and cellular proteins along the long control region of human papillomavirus type 18.
    J Virol. 1988 Nov;62(11):4321-30 PMID: 2845145
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1992-10-00
Pages
5949-58
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC241472
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]